AFP and hepatocellular carcinoma: These discrepancies underline the complex role of AFP as a prognostic biomarker in HCC and suggest that the relationship between AFP levels and treatment outcomes may be influenced by factors such as the specific treatment regimen and patient heterogeneity, emphasizing the need for further studies.